Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Insulin imbalance may not be the only cause of diabetes

In Switzerland, more than 400,000 people suffer from type 2 diabetes, a serious metabolic disorder that is constantly increasing.

11 Sep 2019

Existing drug could be used to treat glioblastoma

A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.

11 Sep 2019

'Weight cycling' may provide metabolic health benefits

Repeatedly losing and regaining weight may lead to improved insulin levels and lower body fat percentages in the long term, even during weight regain phases.

10 Sep 2019

New study supports link between enteroviral infections and type 1 diabetes

Enteroviral infections are common viral infections with usually rather few symptoms, and they are also believed to be linked to the onset of type 1 diabetes.

10 Sep 2019

Study sheds light on how 'flight-or-flight' response impairs long-term health

Research from the lab of Mark Alkema, PhD, professor of neurobiology, sheds light on how the "flight-or-flight" response impairs long-term organism health.

10 Sep 2019

Economic resurgence not associated with improvement in cardiovascular health

A new study published in the American Journal of Medicine by the University of Alabama at Birmingham indicates that economic resurgence was not associated with improvement in cardiovascular health among American adults after the great economic recession of 2008-2009.

8 Sep 2019

UAB researchers identify biomarker for early beta cell death in Type 1 diabetes

Beta cells in the pancreas produce insulin. Their death is a key feature of Type 1 diabetes, and that loss starts long before diagnosis. However, there has been no straightforward way to measure that early loss.

8 Sep 2019

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

Scientists at The University of Texas at Dallas have found evidence suggesting that resistance to the "hunger hormone" ghrelin in the brain is linked to the cognitive impairments and memory loss associated with Alzheimer's disease.

4 Sep 2019

Diabetes associated with increased risk of developing heart failure after a heart attack

After a heart attack, patients with diabetes are at greater risk of heart failure and subsequent death than those without diabetes, according to late breaking results from the FAST-MI registry presented today at ESC Congress 2019 together with the World Congress of Cardiology.

4 Sep 2019

Unhealthy lifestyle raises heart disease risk more than genetics

A new study has found that an unhealthy lifestyle increases a person’s risk of heart disease significantly more than a person’s genetic make-up.

3 Sep 2019

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

Researchers have used CRISPR-Cas9 to treat obesity and type 2 diabetes in mice, a development that could eventually benefit humans.

3 Sep 2019

Metabolic surgery improves health in obese diabetics

Paris is hosting the European Society of Cardiology Congress (ESC) meet this year where on the 2nd of September researchers from the Cleveland Clinic reveal that weight loss surgeries in patients with obesity and type 2 diabetes could reduce the risk death and major untoward heart or cardiovascular events or major adverse cardiovascular events (MACE).

3 Sep 2019

Discovery may help identify signs of type 1 diabetes earlier

A new study showed that there are significant differences in the MHC class II antigens on the insulin peptide that is deficient in type 1 diabetes mellitus (T1DM). These determine the response of the T cells to the insulin peptide that causes destruction of insulin.

2 Sep 2019

Exercise during pregnancy shown to restore metabolic health

A new study has shown that exercise can restore key tissues and reduce the risk of metabolic disorders such as type 2 diabetes.

2 Sep 2019

New discovery may help identify type 1 diabetes earlier than is currently possible

Type 1 diabetes, an autoimmune disease that typically emerges before the age of 20, wipes out the body's ability to produce insulin--a hormone that's essential to life. Diagnosis often comes after symptoms arise, at which point the disease has taken hold.

30 Aug 2019

Shopping at the Apotheke: Compare German pharmacies with your corner drugstore

If you're looking for bobby pins, cheap lipstick or a protein bar, well, sorry, Americans, the German pharmacy can't help you.

30 Aug 2019

New NC State-led project to focus on the future of biomanufacturing

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

29 Aug 2019

Islet-on-a-Chip to study the fundamental biology of diabetes

By combining two powerful technologies, scientists are taking diabetes research to a whole new level. In a study led by Harvard University's Kevin Kit Parker, microfluidics and human, insulin-producing beta cells have been integrated in an "Islet-on-a-Chip".

29 Aug 2019

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with MannKind Corporation, a biopharmaceutical company focused on inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.

From Tanner Pharma Group 29 Aug 2019

How much control is too much in type 1 diabetes?

Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.

29 Aug 2019